Article History
Received: 31 May 2018
Accepted: 3 September 2018
First Online: 12 September 2018
Ethics approval and consent to participate
: The use of laboratory genetic information was approved by the Hong Kong Hospital Authority/Hong Kong East Cluster Institutional Review Board Ethics Committee (HKEC-2016-047; approval date: 23 August 2016). Written informed consent for genetic testing and participating in the study was obtained from the subject’s parents, on behalf of the minor subject. There was no treatment intervention involved in the study.
: Informed consent to publish this case report, including clinical images, and personal/ clinical details that could compromise anonymity, was obtained from the subject’s parents on behalf of the minor subject.
: DBS and urine testing at National Taiwan University Hospital was provided freely by Sanofi Genzyme, USA. Sanofi Genzyme had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results. Other than above, the authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.